Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Simvastatin (Primary) ; Zoledronic acid (Primary)
- Indications Multiple myeloma
- Focus Biomarker; Pharmacodynamics
- 21 Nov 2016 Planned primary completion date changed from 1 Oct 2014 to 1 Nov 2016.
- 21 Nov 2016 Status changed from recruiting to discontinued because Principal Investigator left institution and thus study not continued.
- 30 Jan 2013 New trial record